(Q24241960)

PubMed publication ID

18646149

19 October 2023

Matthew J Cates

series ordinal

2

author given names

Matthew J

author last names

Cates

1 reference

PubMed publication ID

18646149

Cochrane Database of Systematic Reviews

19 October 2023

language of work or name

English

0 references

publication date

2008

0 references

published in

0 references

issue

3

0 references

page(s)

CD006363

0 references

cites work

Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Cardiovascular side effects of inhaled salbutamol in hypoxic asthmatic patients

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Comparative study of extended release albuterol sulfate and long-acting inhaled salmeterol xinafoate in the treatment of nocturnal asthma

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

The cardio-toxicity of isoprenaline during hypoxia

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Salmeterol: a four week study of a long-acting beta-adrenoceptor agonist for the treatment of reversible airways disease

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Eosinophilic Inflammation in Asthma

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Interaction revisited: the difference between two estimates

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Serious adverse events and death associated with treatment using long-acting beta-agonists

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Interactions between corticosteroids and beta2-agonists

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Recovery from bronchoconstriction and bronchodilator tolerance

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Current issues with beta2-adrenoceptor agonists: pharmacology and molecular and cellular mechanisms

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Airway hyperresponsiveness as a determinant of the early asthmatic response to inhaled allergen

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Effects of long-acting bronchodilators and placebo on histamine-induced asthma symptoms and mild bronchusobstruction

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Salmeterol HFA is as effective as salmeterol CFC in children and adults with persistent asthma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Salmeterol (Serevent) asthma trial halted early

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Acute effects of higher than customary doses of salmeterol and salbutamol in patients with acute exacerbation of COPD.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Beta-agonist intrinsic efficacy: measurement and clinical significance

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Effectiveness and safety of salmeterol in nonspecialist practice settings

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Asthma. From bronchoconstriction to airways inflammation and remodeling

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Airway hyperresponsiveness in asthma: not just a matter of airway inflammation

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Long-term cardiovascular safety of salmeterol powder pharmacotherapy in adolescent and adult patients with chronic persistent asthma: a randomized clinical trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

The cardiorespiratory response to submaximal exercise in subjects with asthma following pretreatment with controlled release oral salbutamol and high-dose inhaled salmeterol

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

A comparison of regular salmeterol vs 'as required' salbutamol therapy in asthmatic children

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Case-control study of salmeterol and near-fatal attacks of asthma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Drug use and pulmonary death rates in increasingly symptomatic asthma patients in the UK

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

A one-week dose-ranging study of inhaled salmeterol in children with asthma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

A 4-week comparison of salmeterol and terbutaline in adult asthma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. UK Study Group

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Beta-adrenoceptors and the epithelial layer in airways

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Beta-adrenoceptors on smooth muscle, nerves and inflammatory cells

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Changes in methacholine induced bronchoconstriction with the long acting beta 2 agonist salmeterol in mild to moderate asthmatic patients

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Systemic effects of salbutamol and salmeterol in patients with asthma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Salmeterol in two different doses in the treatment of nocturnal bronchial asthma poorly controlled by other therapies

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Beta-adrenergic receptors and their regulation.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Salmeterol xinafoate in children on high dose inhaled steroids

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Role of Autonomic Nervous System and the Cough Reflex in the Increased Responsiveness of Airways in Patients with Obstructive Airway Disease*

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Further observations on the cardiotoxicity of isoprenaline during hypoxia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Regular inhaled beta-agonist treatment in bronchial asthma.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Inhaled salmeterol in the treatment of patients with moderate to severe reversible obstructive airways disease--a 3-month comparison of the efficacy and safety of twice-daily salmeterol (100 micrograms) with salmeterol (50 micrograms)

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Salmeterol and prolonged treatment of asthma: international clinical data

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Inhaled beta 2-adrenoceptor agonists in asthma: help or hindrance?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Subsensitivity to the bronchodilator action of albuterol produced by chronic administration

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

The pathology of asthma, with special reference to changes in the bronchial mucosa

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Salbutamol: a new, selective beta-adrenoceptive receptor stimulant

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Airway subsensitivity with long-acting beta 2-agonists. Is there cause for concern?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

The effects of inhaled albuterol and salmeterol in 2- to 5-year-old asthmatic children as measured by impulse oscillometry

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Comparison of powder and aerosol formulations of salmeterol in the treatment of asthma

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Efficacy, safety, and impact on quality of life of salmeterol in patients with moderate persistent asthma.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Potential masking effects of salmeterol on airway inflammation in asthma

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Onset of bronchodilation and finger tremor induced by salmeterol and salbutamol in asthmatic patients

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Efficacy of salmeterol xinafoate powder in children with chronic persistent asthma

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Treatment of nocturnal airway obstruction improves daytime cognitive performance in asthmatics.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Salmeterol versus theophylline in the treatment of asthma

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Dose-response study of inhaled salmeterol in asthmatic patients with 24-hour spirometry and Holter monitoring

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Salmeterol inhaler using a non-chlorinated propellant, HFA134a: systemic pharmacodynamic activity in healthy volunteers

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Hypokalemia from Beta2-Receptor Stimulation by Circulating Epinephrine

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Observations on recent increase in mortality from asthma

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

2 new groups of selective stimulants of adrenergic beta-receptors.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Bitolterol and albuterol metered-dose aerosols: comparison of two long-acting beta 2-adrenergic bronchodilators for treatment of asthma

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Intracoronary injections of salbutamol demonstrate the presence of functional beta 2-adrenoceptors in the human heart

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

A model of the mechanics of airway narrowing.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Comparative protective effect of the inhaled beta 2-agonist salbutamol (albuterol) on bronchoconstriction provoked by histamine, methacholine, and adenosine 5'-monophosphate in asthma

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Salmeterol powder compared with albuterol aerosol as maintenance therapy for asthma in adolescent and adult patients.

30 May 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006363.PUB2

Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. Salmeterol Quality of Life Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006363.PUB2

Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006363.PUB2

Efficacy and safety of fluticasone propionate/salmeterol HFA 134A MDI in patients with mild-to-moderate persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006363.PUB2

The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006363.PUB2

Salmeterol compared with slow-release terbutaline in nocturnal asthma. A multicenter, randomized, double-blind, double-dummy, sequential clinical trial. French Multicenter Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006363.PUB2

Prevention of exercise-induced bronchospasm in pediatric asthma patients: A comparison of two salmeterol powder delivery devices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006363.PUB2

A placebo-controlled clinical trial of regular monotherapy with short-acting and long-acting beta(2)-agonists in allergic asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006363.PUB2

Comparison of the short-term effects of salmeterol and formoterol on heart rate variability in adult asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006363.PUB2

Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006363.PUB2

Misleading data analyses in salmeterol (SMART) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006363.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006363.PUB2

Effect of salmeterol on seasonal changes in airway responsiveness and exhaled nitric oxide in pollen-sensitive asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006363.PUB2

A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006363.PUB2

Comparison of the Bronchodilator Effect of Inhaled Short- and Long-Acting beta(2)-Agonists in Children with Bronchial Asthma: A Randomised Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006363.PUB2

Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006363.PUB2

Lack of Evidence for Beta-2 Receptor Selectivity: a Study of Metaproterenol, Fenoterol, Isoproterenol, and Epinephrine in Patients with Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006363.PUB2

Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006363.PUB2

Characterization of airway plugging in fatal asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006363.PUB2

Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006363.PUB2

Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006363.PUB2

Comparison of the Relative Efficacy of Formoterol and Salmeterol in Asthmatic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006363.PUB2

Current issues with beta2-adrenoceptor agonists: historical background.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Salmeterol versus sodium cromoglycate for the protection of exercise induced asthma in children--a randomised cross-over study

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

The effect of time on the perception of dyspnea following inhaled long-acting bronchodilator

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Inhaled corticosteroids, combined with long-acting beta(2)-agonists, improve the perception of bronchoconstriction in asthma

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4015854

Bronchodilator response to salbutamol after chronic dosing with salmeterol or placebo

29 November 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006363.PUB2

Salmeterol does not cause tolerance during long-term asthma therapy

21 January 2018

1 reference

12 December 2020

Tolerance to beta-agonists during acute bronchoconstriction

1 reference

12 December 2020

The efficacy and safety of inhaled salmeterol 50 microg bd in older patients with reversible airflow obstruction

1 reference

12 December 2020

A 1-week dose-ranging study of inhaled salmeterol in patients with asthma

1 reference

12 December 2020

Comparison of inhaled salmeterol and individually dose-titrated slow-release theophylline in patients with reversible airway obstruction. European Study Group

1 reference

12 December 2020

Efficacy and safety of salmeterol in childhood asthma

1 reference

12 December 2020

A randomized, placebo-controlled study to evaluate the role of salmeterol in the in-hospital management of asthma

1 reference

12 December 2020

The efficacy and tolerability of inhaled salmeterol and individually dose-titrated, sustained-release theophylline in patients with reversible airways disease

1 reference

12 December 2020

Asthma mortality. Why the United States was spared an epidemic of deaths due to asthma

1 reference

12 December 2020

One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group

1 reference

12 December 2020

Efficacy of salmeterol in the treatment of childhood asthma

1 reference

12 December 2020

Effects of inhaled salmeterol and salbutamol (albuterol) on morning dips compared in intensive care patients recovering from an acute severe asthma attack

1 reference

12 December 2020

Onset and duration of action of single doses of formoterol inhaled via Turbuhaler

1 reference

12 December 2020

A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group

1 reference

12 December 2020

Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis

1 reference

12 December 2020

[Therapy of nocturnal asthma: salmeterol versus nocturnal administration of retard theophylline--comparison of effectiveness and tolerance]

1 reference

12 December 2020

Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma

1 reference

12 December 2020

The structure of large and small airways in nonfatal and fatal asthma

1 reference

12 December 2020

[Efficacy of and tolerance to salmeterol compared to salbutamol in patients with bronchial asthma]

1 reference

12 December 2020

The Influence of Polymorphism at Position 16 of the β2-Adrenoceptor on the Development of Tolerance to β-Agonist

1 reference

12 December 2020

Effect of addition of inhaled salmeterol to the treatment of moderate-to-severe asthmatics uncontrolled on high-dose inhaled steroids. European Respiratory Study Group

1 reference

12 December 2020

Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study

1 reference

12 December 2020

Effects of salmeterol in patients with persistent asthma receiving inhaled corticosteroid plus theophylline

1 reference

12 December 2020

Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol

1 reference

12 December 2020

Salmeterol compared with current therapies in chronic asthma

1 reference

12 December 2020

Comparison of beclomethasone, salmeterol, and placebo in children with asthma

1 reference

12 December 2020

Effect of a single dose of inhaled salmeterol on baseline airway caliber and methacholine-induced airway obstruction in asthmatic children

1 reference

12 December 2020

The long‐acting β2‐agonist salmeterol xinafoate: effects on airway inflammation in asthma

1 reference

12 December 2020

Clinical effects of epinephrine by inhalation; a survey

1 reference

12 December 2020

Inflammation and airway function in asthma: what you see is not necessarily what you get

1 reference

12 December 2020

Comparison of salmeterol with disodium cromoglycate in the treatment of adult asthma

1 reference

12 December 2020

Safety of salmeterol in the maintenance treatment of asthma

1 reference

12 December 2020

The role of intrinsic efficacy in determining response to a beta2-agonist in acute severe asthma

1 reference

12 December 2020

1 reference

12 December 2020

Regular inhaled salbutamol and airway responsiveness to allergen

1 reference

12 December 2020

HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis

1 reference

12 December 2020

Duration and magnitude of action of 50 and 100 micrograms of inhaled salmeterol in protecting against bronchoconstriction induced by hyperventilation of dry cold air in subjects with asthma

1 reference

12 December 2020

Usefulness of salmeterol in nocturnal asthma: a comparative study with theophylline-ketotifen association. A French multicenter group

1 reference

12 December 2020

Effect on airway responsiveness of six weeks treatment with salmeterol

1 reference

12 December 2020

Myofibroblasts and subepithelial fibrosis in bronchial asthma

1 reference

12 December 2020

An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist

1 reference

12 December 2020

Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma

1 reference

12 December 2020

Exacerbations of asthma in patients on salmeterol

1 reference

12 December 2020

Long-acting beta 2-agonist salmeterol compared with albuterol in maintenance asthma therapy

1 reference

12 December 2020

Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group

1 reference

12 December 2020

Incidence of acute decreases in peak expiratory flow following the use of metered-dose inhalers in asthmatic patients

1 reference

12 December 2020

Salmeterol prevents aspirin-induced attacks of asthma and interferes with eicosanoid metabolism

1 reference

12 December 2020

Aerosolized terbutaline in asthmatics: development of subsensitivity with long-term administration

1 reference

12 December 2020

Altered cardiovascular autonomic regulation after salmeterol treatment in asthmatic children

1 reference

12 December 2020

Characteristics of the Inflammatory response in bronchial lavage fluids from patients with status asthmaticus

1 reference

12 December 2020

Acute cardiovascular effects of salmeterol in subjects with stable bronchial asthma

1 reference

12 December 2020

[Salmeterol improves the control of disease in patients with moderate asthma. A comparative study of inhaled salmeterol 50 mg and salbutamol depot tablets 8 mg, both administered twice daily]

1 reference

12 December 2020

Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group

1 reference

12 December 2020

Efficacy and duration of salmeterol powder inhalation in protecting against exercise-induced bronchoconstriction

1 reference

12 December 2020

Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma

1 reference

12 December 2020

A twelve-week comparison of salmeterol and salbutamol in the treatment of mild-to-moderate asthma: a Canadian multicenter study

1 reference

12 December 2020

Has the change to beta-agonists combined with oral theophylline increased cases of fatal asthma?

1 reference

12 December 2020

Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma

1 reference

12 December 2020

A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma

1 reference

12 December 2020

Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week

1 reference

12 December 2020

Bronchodilator response to albuterol after regular formoterol and effects of acute corticosteroid administration

1 reference

12 December 2020

Bronchial hyperreactivity

1 reference

12 December 2020

A Single-dose Comparison of Inhaled Albuterol and Two Formulations of Salmeterol on Airway Reactivity in Asthmatic Subjects

1 reference

12 December 2020

Concluding remarks: can we explain the association of beta-agonists with asthma mortality? A hypothesis

1 reference

12 December 2020

Asthma exacerbations in patients taking regular salmeterol, or salbutamol for symptoms

1 reference

12 December 2020

A comparative study in atopic subjects with asthma of the effects of salmeterol and salbutamol on allergen-induced bronchoconstriction, increase in airway reactivity, and increase in urinary leukotriene E4 excretion

1 reference

12 December 2020

Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness

1 reference

12 December 2020

Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma

1 reference

12 December 2020

Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action

1 reference

12 December 2020

Pilgrim's progress: the effect of salmeterol in older children with chronic severe asthma

1 reference

12 December 2020

Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Salmeterol administration by metered-dose inhaler alone vs metered-dose inhaler plus valved holding chamber

1 reference

12 December 2020

A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma

1 reference

12 December 2020

Addition of inhaled salmeterol to inhaled corticosteroids in patients with poorly controlled nocturnal asthma

1 reference

12 December 2020

Clinical evaluation of isopropyl-epinephrine in management of bronchial asthma

1 reference

12 December 2020

Long-term treatment of asthmatic patients with salmeterol vs slow-release theophylline

1 reference

12 December 2020

A comparison of the speeds of action of salmeterol and salbutamol in reversing methacholine-induced bronchoconstriction

1 reference

12 December 2020

Comparison of the effects of tulobuterol patch and salmeterol in moderate to severe asthma

1 reference

12 December 2020

Neue broncholytisch hochwirksame Körper der Adrenalinreihe

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006363.PUB2

7 January 2021